[ET Net News Agency, 28 April 2025] Nomura raised the target price for Pharmaron (03759)
to HKD16.19 from HKD14.31 and maintained the "buy" rating.
The research house said it cuts FY25F/FY26F top-line forecasts by 7.5%/10.0%, reflecting
the company's weaker than expected FY24 results. (rc)